Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do antibiotics maintain antibiotic resistance?

Heinemann1, Ankenbauer, Amábile-Cuevas

  • 1Department of Plant and Microbial Sciences, University of Canterbury, Christchurch, New Zealand.

Drug Discovery Today
|May 2, 2000
PubMed
Summary

Reducing antibiotic use may not restore drug effectiveness. Resistance genes can gain new functions, turning initial costs into advantages, necessitating novel drug designs to promote susceptible microorganisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

P(6) Manganocene and P(3) Cymantrene: Consequences of the Inclusion of Phosphorus Atoms in Mn-Coordinated Cyclopentadienyl Ligands This work was supported by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie. A.E., M.H., and M.Z. thank the DFG-Graduiertenkolleg ("Phosphorchemie als Bindeglied verschiedener chemischer Disziplinen" of the University of Kaiserslautern) and M.Z. also thanks the Studienstiftung des Deutschen Volkes for fellowships.

Angewandte Chemie (International ed. in English)·2000
Same author

Funding for knowledge-sake - Letter.

Drug discovery today·2000
Same author

Spontaneous Assembly of a Schiff Base Tetramacrocycle We thank Professor D. Sellmann and Priv.-Doz. Dr. T. Clark (Universität Erlangen-Nürnberg) for generous suppport of this work. We also thank Professor R. Robson (University of Melbourne, Parkville, Victoria, Australia) for his interest in the results presented here. Financial support by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie is gratefully acknowledged.

Angewandte Chemie (International ed. in English)·2000
Same author

How antibiotics cause antibiotic resistance.

Drug discovery today·1999
Same author

Characterization of Silylated Silicas by Inverse Gas Chromatography: Modelization of the Poly(dimethylsiloxane) Monomer Unit/Surface Interactions Using Poly(dimethylsiloxane) Oligomers as Probes

Journal of colloid and interface science·1996
Same author

Tracking algorithm for the stable spin polarization field in storage rings using stroboscopic averaging.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·1996

Area of Science:

  • Microbiology
  • Evolutionary Biology
  • Pharmacology

Background:

  • Antibiotic resistance in human pathogens is a significant public health concern.
  • Widespread use of antibiotics in medicine and agriculture drives the evolution of resistant strains.
  • The assumption that reducing antibiotic usage will automatically restore drug effectiveness is widely held.

Purpose of the Study:

  • To investigate the complex relationship between antibiotic resistance and susceptibility evolution.
  • To challenge the notion that resistance and susceptibility are simple opposing forces.
  • To explore the potential for resistance genes to acquire new functions and advantages.

Main Methods:

  • The study employs a theoretical and conceptual approach, analyzing evolutionary principles.

Related Experiment Videos

  • It examines the dynamics of gene function evolution in microbial populations under antibiotic pressure.
  • The authors synthesize existing research on antibiotic resistance mechanisms.

    • Main Results:

    • Resistance evolution and susceptibility evolution are not merely opposite sides of the same phenomenon.
    • Antibiotic resistance genes can acquire novel functions, potentially conferring benefits beyond mere resistance.
    • The initial fitness costs associated with resistance can diminish or even reverse over time.

    Conclusions:

    • Reducing antibiotic usage alone may be insufficient to regain lost drug efficacy.
    • Fundamental changes in antibiotic design are required to counteract the evolution of resistance.
    • Future drug development should aim to actively promote the evolution of susceptible microbial populations.